Novartis AG (XSWX:NOVNEE) General and Admin. Expense: CHF0 Mil (TTM As of Mar. 2026)


XSWX:NOVNEE Novartis AG XSWX:NOVNEE
82 GF Score
Price CHF119.30
GF Value CHF96.45
! 7 Warning Signs
View Full Analysis

What is Novartis AG General and Admin. Expense?

Novartis AG XSWX:NOVNEE -0.52% 82 General and Admin. Expense is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:NOVNEE with a GF Score™ of 82/100 and a GF Value™ of CHF96.45. The stock has 7 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Novartis AG's General and Admin. Expense for the three months ended in Mar. 2026 was CHF0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF0 Mil.

Novartis AG General and Admin. Expense Related Terms

Novartis AG General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Novartis AG's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG General and Admin. Expense Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Novartis AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:NOVNEE
82GF Score
Novartis AG XSWX:NOVNEE
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of CHF0 Mil mean?
Novartis AG (XSWX:NOVNEE) has a General and Admin. Expense of CHF0 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Novartis AG and its competitors.
Is Novartis AG's General and Admin. Expense too high?
Novartis AG's current General and Admin. Expense is CHF0 Mil. Overall, Novartis AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's General and Admin. Expense compare to LLY and JNJ?
Novartis AG's General and Admin. Expense of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Novartis AG and its competitors. Novartis AG's current General and Admin. Expense is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (XSWX:NOVNEE) has a current General and Admin. Expense of CHF0 Mil. The stock's GF Value™ is CHF96.45, compared to a current price of CHF119.30 — trading 23.7% above its estimated fair value. The current General and Admin. Expense is CHF0 Mil. Novartis AG's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Novartis AG (XSWX:NOVNEE), the current General and Admin. Expense is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (XSWX:NOVNEE) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF119.30 is trading 23.7% above its estimated GF Value™ of CHF96.45.

Key valuation signals for XSWX:NOVNEE:

  • General and Admin. Expense: CHF0 Mil
  • GF Value™: CHF96.45 vs. price of CHF119.30 (23.7% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the XSWX:NOVNEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
82GF Score

Get the complete analysis for XSWX:NOVNEE

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF119.30
Price
CHF96.45
GF Value